MORF Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 25.60%

Insider Buying (Last 12 Months): $49,440.00

Insider Selling (Last 12 Months): $8,004,797.42

Morphic Insider Trading History Chart

Morphic Share Price & Price History

^$56.99

+0.30 (1.20%)

As of 08/16/2024 01:00 AM ET

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

Morphic Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/8/2024	Bruce Rogers	President	Sell	20,000	$55.79	$1,115,800.00	149,883
7/8/2024	Marc Schegerin	CFO	Sell	43,936	$55.80	$2,451,628.80	37,907
7/8/2024	Praveen P Tipirneni	CEO	Sell	21,582	$55.79	$1,204,059.78	42,460
7/8/2024	Robert E. Farrell, Jr.	CAO	Sell	30,272	$55.80	$1,689,177.60	13,781
7/8/2024	William Devaul	General Counsel	Sell	10,000	$55.79	$557,900.00	23,029
1/16/2024	Bruce Rogers	President	Sell	6,314	$27.49	$173,571.86	142,036
1/16/2024	Marc Schegerin	CFO	Sell	6,041	$27.49	$166,067.09	37,460
1/16/2024	Praveen P Tipirneni	CEO	Sell	13,923	$27.49	$382,743.27	42,013
1/16/2024	Robert E. Farrell, Jr.	CAO	Sell	5,089	$27.49	$139,896.61	34,992
1/16/2024	William Devaul	General Counsel	Sell	4,509	$27.49	$123,952.41	23,029
11/13/2023	Joseph P Slattery	Director	Buy	2,400	$20.60	$49,440.00	9,066
9/7/2023	Marc Schegerin	CFO	Sell	20,000	$54.34	$1,086,800.00	24,136
8/1/2023	Praveen P Tipirneni	CEO	Sell	3,597	$57.04	$205,172.88	13,936
7/3/2023	Praveen P Tipirneni	CEO	Sell	3,597	$57.04	$205,172.88	13,936
6/12/2023	Praveen P Tipirneni	CEO	Sell	840	$63.01	$52,928.40	13,936
6/7/2023	William Devaul	General Counsel	Sell	7,756	$60.05	$465,747.80	13,338
6/1/2023	Praveen P Tipirneni	CEO	Sell	3,597	$57.14	$205,532.58	13,936
5/23/2023	Robert E. Farrell, Jr.	CAO	Sell	10,000	$60.00	$600,000.00	23,708
5/23/2023	William Devaul	General Counsel	Sell	3,802	$60.03	$228,234.06	21,194
5/3/2023	Praveen P Tipirneni	CEO	Sell	3,597	$51.11	$183,842.67	13,936
5/3/2023	Timothy A. Springer	Director	Buy	1,050,000	$45.00	$47,250,000.00	2,768,464
4/25/2023	Bruce Rogers	President	Sell	30,000	$53.40	$1,602,000.00	117,055
4/25/2023	Marc Schegerin	CFO	Sell	50,000	$54.71	$2,735,500.00	24,136
4/25/2023	Praveen P Tipirneni	CEO	Sell	25,179	$53.40	$1,344,558.60	13,936
4/25/2023	Robert E. Farrell, Jr.	CAO	Sell	10,000	$54.71	$547,100.00	12,222
4/20/2023	Robert E. Farrell, Jr.	CAO	Sell	10,000	$45.00	$450,000.00	12,222
4/17/2023	Bruce Rogers	President	Sell	10,000	$40.35	$403,500.00	117,055
4/17/2023	Robert E. Farrell, Jr.	CAO	Sell	20,000	$41.25	$825,000.00	2,222
3/7/2023	Marc Schegerin	CFO	Sell	50,000	$45.00	$2,250,000.00	17,074
2/14/2023	Bruce Rogers	President	Sell	10,000	$40.09	$400,900.00	116,192
1/14/2023	Bruce Rogers	President	Sell	1,778	$30.63	$54,460.14	116,192
1/14/2023	Marc Schegerin	CFO	Sell	1,670	$30.63	$51,152.10	16,212
1/14/2023	Praveen P Tipirneni	CEO	Sell	4,027	$30.63	$123,347.01	12,679
1/14/2023	Robert E. Farrell, Jr.	CAO	Sell	1,248	$30.63	$38,226.24	22,222
1/14/2023	William Devaul	General Counsel	Sell	1,169	$30.63	$35,806.47	23,739
4/1/2022	Bruce Rogers	Insider	Sell	10,000	$41.03	$410,300.00

The Final Frontier

From Porter & Company | Ad

And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Morphic (NASDAQ:MORF)

94.25% of Morphic stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Morphic Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	73,000	$2.49M	0.0%	N/A	0.146%
8/20/2024	Novo Holdings A S	375,000	$12.78M	0.6%	N/A	0.749%
8/16/2024	Algert Global LLC	33,108	$1.13M	0.0%	+99.7%	0.066%
8/15/2024	The Manufacturers Life Insurance Company	85,966	$2.93M	0.0%	+4.9%	0.172%
8/15/2024	Affinity Asset Advisors LLC	250,573	$8.54M	1.0%	+11.4%	0.500%
8/14/2024	Point72 Asset Management L.P.	1,461,302	$49.79M	0.1%	-68.8%	2.917%
8/14/2024	ProShare Advisors LLC	8,531	$0.29M	0.0%	-17.6%	0.017%
8/14/2024	Profund Advisors LLC	14,033	$0.48M	0.0%	-59.1%	0.028%
8/13/2024	Ensign Peak Advisors Inc	113,883	$3.88M	0.0%	-19.4%	0.227%
8/12/2024	Inspire Investing LLC	10,227	$0.35M	0.0%	N/A	0.020%
8/9/2024	Edgestream Partners L.P.	17,760	$0.61M	0.0%	N/A	0.035%
8/9/2024	Dimensional Fund Advisors LP	208,225	$7.09M	0.0%	-5.8%	0.416%
8/8/2024	American Century Companies Inc.	23,134	$0.79M	0.0%	+254.4%	0.046%
8/6/2024	Candriam S.C.A.	214,154	$7.30M	0.0%	-14.3%	0.428%
8/5/2024	Arizona State Retirement System	8,404	$0.29M	0.0%	+2.5%	0.017%
8/5/2024	Victory Capital Management Inc.	28,520	$0.97M	0.0%	-2.0%	0.057%
8/3/2024	TD Asset Management Inc	112,100	$3.82M	0.0%	-11.0%	0.223%
8/1/2024	Rhumbline Advisers	65,379	$2.23M	0.0%	+26.5%	0.130%
7/31/2024	nVerses Capital LLC	2,300	$78K	0.0%	+109.1%	0.005%
7/26/2024	Bank of New York Mellon Corp	152,374	$5.19M	0.0%	+22.0%	0.304%
7/18/2024	Assenagon Asset Management S.A.	88,962	$3.03M	0.0%	+24.6%	0.178%
7/12/2024	SG Americas Securities LLC	8,691	$0.30M	0.0%	N/A	0.017%
7/5/2024	DNB Asset Management AS	7,202	$0.25M	0.0%	+9.3%	0.014%
5/28/2024	Teachers Retirement System of The State of Kentucky	17,167	$0.60M	0.0%	+14.8%	0.034%
5/21/2024	LRI Investments LLC	1,000	$35K	0.0%	N/A	0.002%
5/17/2024	Artal Group S.A.	2,213,188	$77.90M	2.0%	+3.5%	4.418%
5/16/2024	California State Teachers Retirement System	30,679	$1.08M	0.0%	-3.1%	0.061%
5/15/2024	Price T Rowe Associates Inc. MD	2,523,586	$88.83M	0.0%	+13.5%	5.038%
5/15/2024	LRI Investments LLC	1,000	$35K	0.0%	N/A	0.002%
5/15/2024	Affinity Asset Advisors LLC	225,000	$7.92M	1.0%	+427.3%	0.449%
5/14/2024	CANADA LIFE ASSURANCE Co	13,173	$0.46M	0.0%	-22.2%	0.026%
5/14/2024	American International Group Inc.	18,797	$0.66M	0.0%	+2.9%	0.038%
5/13/2024	Seven Eight Capital LP	22,835	$0.80M	0.1%	N/A	0.046%
5/10/2024	Vanguard Group Inc.	2,261,195	$79.59M	0.0%	-2.6%	4.514%
5/9/2024	State Board of Administration of Florida Retirement System	11,045	$0.42M	0.0%	+12.2%	0.022%
5/8/2024	ProShare Advisors LLC	10,359	$0.37M	0.0%	+11.9%	0.021%
5/7/2024	Swiss National Bank	58,900	$2.07M	0.0%	+3.9%	0.118%
5/1/2024	Capstone Investment Advisors LLC	6,348	$0.22M	0.0%	N/A	0.013%
5/1/2024	BNP Paribas Financial Markets	47,021	$1.66M	0.0%	-46.8%	0.094%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	19,288	$0.70M	0.0%	-18.8%	0.039%
4/29/2024	China Universal Asset Management Co. Ltd.	9,630	$0.34M	0.0%	+67.4%	0.019%
4/24/2024	Assenagon Asset Management S.A.	71,384	$2.51M	0.0%	-26.7%	0.143%
3/5/2024	Wellington Management Group LLP	3,377,310	$97.54M	0.0%	-1.3%	6.749%
3/1/2024	Goldman Sachs Group Inc.	635,064	$18.34M	0.0%	+88.2%	1.269%
2/26/2024	Perceptive Advisors LLC	56,980	$1.65M	0.0%	N/A	0.114%
2/15/2024	Brandywine Managers LLC	20,286	$0.59M	0.6%	N/A	0.041%
2/14/2024	Point72 Asset Management L.P.	4,591,000	$132.59M	0.3%	+83.3%	9.230%
2/13/2024	Affinity Asset Advisors LLC	42,670	$1.23M	0.2%	-80.6%	0.086%
2/13/2024	Rafferty Asset Management LLC	202,726	$5.86M	0.0%	+45.7%	0.408%
2/13/2024	Finepoint Capital LP	496,856	$14.35M	4.1%	+52.7%	0.999%
2/12/2024	Allianz Asset Management GmbH	83,487	$2.41M	0.0%	N/A	0.168%
2/12/2024	TD Asset Management Inc	88,718	$2.56M	0.0%	-4.7%	0.178%
2/9/2024	Dynamic Technology Lab Private Ltd	13,354	$0.39M	0.0%	+39.2%	0.027%
2/7/2024	BNP Paribas Financial Markets	88,351	$2.55M	0.0%	+98.5%	0.178%
2/7/2024	E Fund Management Co. Ltd.	10,888	$0.31M	0.0%	N/A	0.022%
2/6/2024	Charles Schwab Investment Management Inc.	319,450	$9.23M	0.0%	+5.0%	0.642%
2/6/2024	Swiss National Bank	56,700	$1.64M	0.0%	-4.5%	0.114%
2/5/2024	Victory Capital Management Inc.	13,630	$0.39M	0.0%	+10.8%	0.027%
2/1/2024	New York State Common Retirement Fund	16,358	$0.47M	0.0%	+25.1%	0.033%
2/1/2024	Jennison Associates LLC	616,950	$17.82M	0.0%	N/A	1.240%
2/1/2024	Handelsbanken Fonder AB	9,400	$0.27M	0.0%	N/A	0.019%
1/31/2024	Federated Hermes Inc.	1,000,000	$28.88M	0.1%	+13.1%	2.010%
1/30/2024	HealthInvest Partners AB	14,952	$0.43M	0.3%	N/A	0.030%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	4,585	$0.13M	0.0%	-25.8%	0.009%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	23,758	$0.69M	0.0%	+12.0%	0.048%
1/24/2024	Arizona State Retirement System	8,039	$0.23M	0.0%	N/A	0.016%
1/24/2024	China Universal Asset Management Co. Ltd.	5,753	$0.17M	0.0%	+364.7%	0.012%
1/17/2024	Assenagon Asset Management S.A.	97,422	$2.81M	0.0%	-17.6%	0.196%
12/18/2023	Vanguard Group Inc.	2,107,410	$48.28M	0.0%	+10.5%	4.237%
12/1/2023	Wellington Management Group LLP	3,421,820	$78.39M	0.0%	+48.5%	6.879%
11/15/2023	iA Global Asset Management Inc.	45,680	$1.05M	0.0%	-9.6%	0.092%
11/15/2023	Seven Eight Capital LP	51,022	$1.17M	0.1%	N/A	0.103%
11/15/2023	Alps Advisors Inc.	35,344	$0.81M	0.0%	+6.9%	0.071%
11/14/2023	MPM Bioimpact LLC	200,000	$4.58M	1.2%	N/A	0.402%
11/14/2023	Schonfeld Strategic Advisors LLC	108,500	$2.49M	0.0%	+272.8%	0.218%
11/14/2023	Fred Alger Management LLC	132,745	$3.04M	0.0%	+36.9%	0.267%
11/13/2023	Federated Hermes Inc.	884,025	$20.25M	0.1%	+1.5%	1.777%
11/13/2023	Silverarc Capital Management LLC	590,829	$13.54M	4.1%	+134.2%	1.188%
11/13/2023	FMR LLC	6,522,060	$149.42M	0.0%	-5.1%	13.112%
11/13/2023	Rafferty Asset Management LLC	139,092	$3.19M	0.0%	+6.9%	0.280%
11/9/2023	Citigroup Inc.	60,116	$1.38M	0.0%	+28.6%	0.121%
11/9/2023	Skandinaviska Enskilda Banken AB publ	13,984	$0.32M	0.0%	N/A	0.028%
11/8/2023	State Board of Administration of Florida Retirement System	9,845	$0.23M	0.0%	+14.0%	0.020%
11/8/2023	Charles Schwab Investment Management Inc.	304,276	$6.97M	0.0%	+14.0%	0.612%
11/8/2023	Swiss National Bank	59,400	$1.36M	0.0%	+1.0%	0.119%
11/8/2023	Amalgamated Bank	4,859	$0.11M	0.0%	+14.0%	0.010%
11/7/2023	Quantbot Technologies LP	6,000	$0.14M	0.0%	N/A	0.013%
11/7/2023	Barclays PLC	73,998	$1.70M	0.0%	+10.5%	0.154%
11/7/2023	Jump Financial LLC	59,596	$1.37M	0.1%	N/A	0.124%
11/6/2023	Assenagon Asset Management S.A.	118,297	$2.71M	0.0%	+77.2%	0.247%
11/6/2023	Victory Capital Management Inc.	12,306	$0.28M	0.0%	-96.2%	0.026%
10/31/2023	China Universal Asset Management Co. Ltd.	1,238	$28K	0.0%	+106.3%	0.003%
10/27/2023	TD Asset Management Inc	93,112	$2.13M	0.0%	+38.5%	0.194%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	21,212	$0.49M	0.0%	+10.4%	0.044%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	6,182	$0.14M	0.0%	+38.1%	0.013%
10/24/2023	Bank of New York Mellon Corp	123,925	$2.84M	0.0%	+12.4%	0.259%
10/13/2023	SG Americas Securities LLC	22,015	$0.50M	0.0%	+1,041.3%	0.046%
8/23/2023	Wolverine Trading LLC	3,962	$0.22M	0.0%	N/A	0.008%
8/21/2023	Affinity Asset Advisors LLC	201,887	$11.57M	4.0%	+48.6%	0.421%
8/15/2023	Silverarc Capital Management LLC	252,309	$14.47M	4.5%	+388.2%	0.527%

Data available starting January 2016

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $56.99

$56.99

50 Day Range

MA: $56.76

$55.74

$56.99

52 Week Range

Now: $56.99

$19.34

$57.00

Volume

400 shs

Average Volume

1,272,131 shs

Market Capitalization

$2.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Morphic?: Morphic's top insider shareholders include:
Timothy A Springer (Director)
Bruce Rogers (President)
Praveen P Tipirneni (CEO)
Marc Schegerin (CFO)
Robert E Farrell Jr (CAO)
William Devaul (General Counsel)
Joseph P Slattery (Director)
Learn More about top insider investors at Morphic.